| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | EP1317484B2 Variants of the phleum pratense phl p 1 allergenic protein |
| 01/05/2011 | EP1307218B1 Treatment of obesity |
| 01/05/2011 | EP1301202B1 Genetically-engineered mhc molecules |
| 01/05/2011 | EP1128814B1 Aerosols comprising nanoparticle drugs |
| 01/05/2011 | EP0815129B1 Ingap protein involved in pancreatic islet neogenesis |
| 01/05/2011 | DE102009025542A1 Detecting intact capsule-forming or non-capsule-forming parasites, e.g. Trichinella papuae, in a meat comprises macerating the meat with a basic digestive solution containing a digestive enzyme, which is active in basic medium |
| 01/05/2011 | DE102007052114B4 Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle A method of modulating the function of the growth or differentiation of a cell |
| 01/05/2011 | CN1997383B Aequorin-containing compositions and methods of using same |
| 01/05/2011 | CN1878562B Antibody therapy |
| 01/05/2011 | CN101939329A Amino acid pairing-based self assembling peptides and methods |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101939024A Compositions for the treatment of inflammation of the gastrointestinal tract |
| 01/05/2011 | CN101939023A An orally administerable solid pharmaceutical composition and a process thereof |
| 01/05/2011 | CN101939022A Methods for treating obesity and obesity related diseases and disorders |
| 01/05/2011 | CN101939021A Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 01/05/2011 | CN101939020A Treatment of metastatic stage prostate cancer with degarelix |
| 01/05/2011 | CN101939019A Methods for preventing or treating insulin resistance |
| 01/05/2011 | CN101939000A Materials and methods for treatment of pathological ocular vascular proliferation |
| 01/05/2011 | CN101938997A Patch with hydrophilic adhesive |
| 01/05/2011 | CN101938974A Skin treatment compositions |
| 01/05/2011 | CN101935669A Detoxication engineering bacteria, and preparation method and application thereof |
| 01/05/2011 | CN101935640A Bacterial colony induction signal degrading enzyme and coding gene and application thereof |
| 01/05/2011 | CN101935352A Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 01/05/2011 | CN101935351A Human vascuoar endothelial cell growth factor analogue |
| 01/05/2011 | CN101935347A Deubiquitination mutant of mda-7/IL-24 |
| 01/05/2011 | CN101935346A Mutated human-source fibroblast growth factor and application in treating endocrine diseases |
| 01/05/2011 | CN101935345A Peptides and APL-type derivatives of HSP60 and pharmaceutical compositions |
| 01/05/2011 | CN101935341A Polypeptide with activity of inhibiting beta-lactamase and preparation method and application thereof |
| 01/05/2011 | CN101934071A Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome |
| 01/05/2011 | CN101934070A Veterinary antibacterial drug composition containing lysozyme and oligosaccharide and application thereof |
| 01/05/2011 | CN101934069A Application of neuroglobin in promoting neurite growth |
| 01/05/2011 | CN101934068A Preparation method of thymopetidum injection |
| 01/05/2011 | CN101934067A Preparation method of polygeline injection |
| 01/05/2011 | CN101934066A Application of actinomycin-class compound actinomycin V in preparing drug capable of resisting breast cancer |
| 01/05/2011 | CN101933949A Application of traditional Chinese medicine medicated leaven in lysozyme-liposome coated with chitosan |
| 01/05/2011 | CN101933897A Recombinant human endostatin temperature-sensitive gel composition for injection |
| 01/05/2011 | CN101933653A Officinal health-care solid electronic aerosolization liquid and preparation method thereof |
| 01/05/2011 | CN101297965B Applications of thymic peptide beta4 in preparing medicament for preventing and treating bronchial asthma |
| 01/04/2011 | US7863436 Short interfering RNA for use in treatment of cell proliferative disorders |
| 01/04/2011 | US7863432 Nucleic acid molecules encoding AKAP18 delta, a splice variant of a protein kinase A anchor protein |
| 01/04/2011 | US7863429 Treatment of inflammatory diseases including psoriasis |
| 01/04/2011 | US7863424 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 01/04/2011 | US7863422 monoclonal antibody inhibits CD4+ T cell, NK cell proliferation, as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs |
| 01/04/2011 | US7863418 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders |
| 01/04/2011 | US7863416 Hexapeptide of given formula; binds with opioid receptor and exhibits agonist and antagonist activity; anxiolytics, diuretics, and anti-cancer agents |
| 01/04/2011 | US7863415 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 01/04/2011 | US7863414 Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain |
| 01/04/2011 | US7863413 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 01/04/2011 | US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents |
| 01/04/2011 | US7863272 Therapy for stroke, cancer, multiple sclerosis, brain disorders, Parkinson's disease, Huntington's diseasee |
| 01/04/2011 | US7863259 adminstering a nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics ( vancomycin, glycylcycline) or equivalent bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug deliver; treating infections; bioavailability |
| 01/04/2011 | US7863258 positively charged chitosan shell, polyglutamic acid core, negative surface charge; enhanced permeability for paracellular drug delivery; pemetrexed; gemcitabine |
| 01/04/2011 | US7863257 Nanoparticles for protein drug delivery |
| 01/04/2011 | US7863247 Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides |
| 01/04/2011 | US7863246 intracerebroventricular delivery of low amounts of vascular endothelial growth factor for enhancing the survival of a motor neuron in a patient diagnosed with a motoneuron disease |
| 01/04/2011 | US7863245 Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesity |
| 01/04/2011 | US7863244 Peptides |
| 01/04/2011 | US7863243 treating a liver cancer by administering to a patient in need thereof an effective amount of adiponectin( protein hormone) in dosage form |
| 01/04/2011 | US7863242 Compositions for down-regulation of CCR5 expression and methods of use thereof |
| 01/04/2011 | US7863241 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease |
| 01/04/2011 | US7863240 Administering a reagent that increases the activity of leptin in a patient with hepatocellular carcinoma, caused by immune suppression, wherein a shift takes place in the Th1/Th2 balance towards a pro-inflammatory state |
| 01/04/2011 | US7863239 polypeptide which is cysteine-knot growth factor family member attached to scaffold such as bis(bromomethyl)benzene; point mutations; treating infection and autoimmune disorders |
| 01/04/2011 | US7863238 endowing a protein with bone-tissue targeting ability and improvement of its stability by means of addition of a short peptide consisting of acidic amino acids to the N-terminus of the protein; osteoporosis |
| 01/04/2011 | US7863031 Recombinant hydrolase for use in enhancing/;improving quality of animal feeds and foodstuffs |
| 01/04/2011 | US7863008 Hepatitis virus; detecting seroconversion; fusion proteins; capsids; immunoassay; kits |
| 01/04/2011 | US7862994 Preventing fusion of virus and preferential cells; incubate cells with genetically engineered viral particles and viricide, detect reduction in emission energy, reduction in emission indicates prevention of viral fusion and infection |
| 01/04/2011 | US7862831 Priming extracellular matrix by treating with a priming agent; adding to the primed extracellular matrix a solution of a polymerizable agent; reacting the primed extracellular matrix and polymerizable agent to create a hydrogel covalently bound to the extracellular matrix |
| 01/04/2011 | US7862828 Allergy vaccines containing hybrid polypeptides |
| 01/04/2011 | US7862826 treating an injury to a nervous system of an animal by applying to the injury an effective amount of an antimicrobial peptide, BDNF, IGF-1, and Substance P, wherein the antimicrobial peptide is BNP-1 and wherein the injury comprises an acute spinal cord injury |
| 01/04/2011 | US7862824 Enhancement of GLP-2 activity of suppressing appetite |
| 01/04/2011 | US7862819 Mammal polynucleotides; binding to monoclonal antibodies |
| 01/04/2011 | US7862818 Using chemokine specific immunoglobulin to prevent and treat inflammatory bowel disease, colitis and/or sarcoidosis |
| 01/04/2011 | US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents |
| 01/04/2011 | US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP) |
| 01/04/2011 | US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins |
| 01/04/2011 | US7862813 Multivalent immunoglobulin polypeptide for treatment of immune system abnormalities |
| 01/04/2011 | US7862811 Protease inhibition for prevention or treatment of heart failure |
| 01/04/2011 | US7862810 Repairing damaged myocardium and/or myocardial cells utilizing differentiated cardiac stem cells; tissue engineering |
| 01/04/2011 | US7862809 Lactobacilic broth prevention or treatment of angiogenic disorders |
| 01/04/2011 | US7862751 solid (cyclosporine, gemfibrozil or fenofibrate) melts under pressure of gas without degrading at temperature lower than melting point, forming solution with carrier, passing through vessel of lower pressure to form particles; encapsulated with biodegradable polyoxyethylene glycol, cellulose acetate |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2516661C M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 01/04/2011 | CA2473973C Method of stimulating growth and resistance to diseases of aquatic organisms |
| 01/04/2011 | CA2468039C Novel peptide having angiotensin converting enzyme inhibitory effect |
| 01/04/2011 | CA2461691C Allograft bone composition having a gelatin binder |
| 01/04/2011 | CA2459013C Proteins having effects of controlling cell migration and cell death |
| 01/04/2011 | CA2451184C Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2447818C Method for purifying an enzyme and purified enzyme produced according to this method, as well as use of the enzyme |
| 01/04/2011 | CA2447335C Targeted delivery of drugs for the treatment of viral infections |
| 01/04/2011 | CA2419423C Conjugates of peptides and peptide mimetics having integrin inhibitor properties |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2384670C Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 01/04/2011 | CA2382848C Diagnostics and therapeutics for osteoporosis |
| 01/04/2011 | CA2381461C Lhrh antagonists having improved solubility properties |
| 01/04/2011 | CA2379909C Drug releasing biodegradable fiber implant |
| 01/04/2011 | CA2369427C Interferon-beta use in the treatment of ewing's family of tumors |
| 01/04/2011 | CA2361181C Her-2 binding antagonists |